Table 7 Drug-related deaths involving only one drug by sex, age and selected drugs reported1, Scotland, 2009
| Heroin / |
Meth- |
Benzodiazepines |
Cocaine |
Ecstasy |
Amphet- |
Alcohol |
|||
|---|---|---|---|---|---|---|---|---|---|
| Any |
of which: |
||||||||
| Diaz- |
Temaz- |
||||||||
| (a) only one drug (and, perhaps, alcohol) was found to be present in the body |
|||||||||
| All such deaths |
36 |
10 |
7 |
6 |
1 |
2 |
1 |
1 |
40 |
| Males |
31 |
9 |
5 |
5 |
0 |
2 |
1 |
1 |
34 |
| Females |
5 |
1 |
2 |
1 |
1 |
0 |
0 |
0 |
6 |
| Under 25 |
8 |
0 |
1 |
1 |
0 |
0 |
1 |
0 |
3 |
| 25-34 |
9 |
6 |
1 |
1 |
0 |
2 |
0 |
0 |
12 |
| 35-44 |
14 |
3 |
2 |
2 |
0 |
0 |
0 |
1 |
15 |
| 45-54 |
4 |
0 |
2 |
1 |
1 |
0 |
0 |
0 |
7 |
| 55 and over |
1 |
1 |
1 |
1 |
0 |
0 |
0 |
0 |
3 |
| Males |
|||||||||
| Under 25 |
6 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
2 |
| 25-34 |
7 |
6 |
1 |
1 |
0 |
2 |
0 |
0 |
11 |
| 35-44 |
14 |
2 |
2 |
2 |
0 |
0 |
0 |
1 |
14 |
| 45-54 |
3 |
0 |
1 |
1 |
0 |
0 |
0 |
0 |
4 |
| 55 and over |
1 |
1 |
1 |
1 |
0 |
0 |
0 |
0 |
3 |
| Females |
|||||||||
| Under 25 |
2 |
0 |
1 |
1 |
0 |
0 |
0 |
0 |
1 |
| 25-34 |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
| 35-44 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
| 45-54 |
1 |
0 |
1 |
0 |
1 |
0 |
0 |
0 |
3 |
| 55 and over |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| (b) only one drug (and, perhaps, alcohol) was implicated in, or potentially contributed to the cause |
|||||||||
| All such deaths |
148 |
54 |
7 |
6 |
1 |
7 |
1 |
3 |
90 |
| Males |
122 |
42 |
5 |
5 |
0 |
6 |
1 |
3 |
72 |
| Females |
26 |
12 |
2 |
1 |
1 |
1 |
0 |
0 |
18 |
| Under 25 |
21 |
6 |
1 |
1 |
0 |
0 |
1 |
0 |
7 |
| 25-34 |
56 |
16 |
1 |
1 |
0 |
4 |
0 |
0 |
36 |
| 35-44 |
51 |
19 |
2 |
2 |
0 |
1 |
0 |
3 |
26 |
| 45-54 |
16 |
10 |
2 |
1 |
1 |
1 |
0 |
0 |
17 |
| 55 and over |
4 |
3 |
1 |
1 |
0 |
1 |
0 |
0 |
4 |
| Males |
|||||||||
| Under 25 |
16 |
6 |
0 |
0 |
0 |
0 |
1 |
0 |
5 |
| 25-34 |
42 |
12 |
1 |
1 |
0 |
3 |
0 |
0 |
30 |
| 35-44 |
47 |
12 |
2 |
2 |
0 |
1 |
0 |
3 |
20 |
| 45-54 |
13 |
9 |
1 |
1 |
0 |
1 |
0 |
0 |
13 |
| 55 and over |
4 |
3 |
1 |
1 |
0 |
1 |
0 |
0 |
4 |
| Females |
|||||||||
| Under 25 |
5 |
0 |
1 |
1 |
0 |
0 |
0 |
0 |
2 |
| 25-34 |
14 |
4 |
0 |
0 |
0 |
1 |
0 |
0 |
6 |
| 35-44 |
4 |
7 |
0 |
0 |
0 |
0 |
0 |
0 |
6 |
| 45-54 |
3 |
1 |
1 |
0 |
1 |
0 |
0 |
0 |
4 |
| 55 and over |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1. Part (a) of this table gives
the number of deaths for which each of the specified drugs was the
only drug which was found to be present in the body. For example, a
death for which:
(a) both cocaine and alcohol were implicated would be counted
twice: once under "cocaine" and once under "alcohol"
(b) both cocaine and alcohol were implicated, and methadone was
found to be present in the body but was not considered to have had
any direct contribution to the death, would NOT be counted at all
in the upper part of the table
The final column of part (a) gives the number of drug-related
deaths for which alcohol was found to be present in the body
together with only one drug
Part (b) of this table gives the number of deaths for which each
of the specified drugs was the only drug which was considered to
have been implicated in, or potentially contributed, to the cause
of death. The pathologist may have reported that other drugs were
present in the body - but, if so, the pathologist did not consider
that they had any direct contribution to the death.
The final column of part (b) gives the number of drug-related
deaths for which alcohol was thought, by the pathologist, to be
implicated in the cause of death together with only one drug
For example, a death for which:
(a) both cocaine and alcohol were implicated would be counted
twice: once under "cocaine" and once under "alcohol"
(b) both cocaine and alcohol were implicated, and methadone was
found to be present in the body but was not considered to have had
any direct contribution to the death, would also be counted under
"cocaine" and "alcohol" (but not under "methadone")
(c) cocaine, methadone and alcohol were ALL implicated would NOT
be counted at all in this table
2. See paragraph 3.3.1 of commentary.